Immunotherapy could help patients with recurrent head and neck cancer live longer
Immunotherapy used only or with chemotherapy shows improved survival in patients with relapsing head and neck cancer than standard aggressive chemotherapy, a new clinical trial result presented at the 2019 American Society of Clinical...